Millipore Sigma Vibrant Logo

343781 ω-Conotoxin GVIA, Conus geographus - CAS 106375-28-4 - Calbiochem

View This Product on Sigma-Aldrich
343781
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
106375-28-4C₁₂₀H₁₈₂N₃₈O₄₃S₆

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
343781-100UGCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      アルミニウムカン 100 μg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewA neurotoxin that acts as an antagonist of voltage-activated N-type Ca2+ channels and of neurotransmitter release at neuronal synapses. Its antagonistic activity is attributed to a tyrosine residue at position 13. Does not bind to dihydropyridine- or verapamil-binding sites. Also reported to inhibit ATP-induced inward currents mediated by P2X2/X3 receptors (IC50 = 21.2 nM for P2X3 and 3.84 µM for P2X2/X3 heterooligomeric receptors).
      Catalogue Number343781
      Brand Family Calbiochem®
      Synonymsω-CgTx GVIA
      References
      ReferencesLalo, U.V., et al. 2001. Brain Res. Bull. 54, 507.
      Kim, J.I., et al. 1995. Biochem. Biophys. Res. Commun. 206, 449.
      Abbott, J.R., and Litzinger, M.J. 1994. Int. J. Dev. Neurosci. 12, 43.
      Olivera, B.M., et al. 1991. J. Biol. Chem. 266, 22067.
      Protti, D.A., et al. 1991. Brain Res. 557, 336.
      Werth, J.L., et al. 1991. Mol. Pharmacol. 40, 742.
      Koyano, K., et al. 1987. Eur. J. Pharmacol. 135, 337.
      Abe, T., et al. 1986. Neurosci. Lett. 71, 203.
      Product Information
      CAS number106375-28-4
      ATP CompetitiveN
      DeclarationNot available for sale outside of the United States.
      FormLyophilized
      Hill FormulaC₁₂₀H₁₈₂N₃₈O₄₃S₆
      Chemical formulaC₁₂₀H₁₈₂N₃₈O₄₃S₆
      ReversibleN
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetVoltage-activated N-type Ca2+ channels
      Primary Target IC<sub>50</sub>21.2 nM for P2X3 and 3.84 µM for P2X2/X3 heterooligomeric receptors
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableN
      Peptide SequenceH-Cys¹-Lys-Ser-Hyp-Gly-Ser-Ser-Cys⁸-Ser-Hyp-Thr-Ser-Tyr-Asn-Cys¹⁵-Cys¹⁶-Arg-Ser-Cys¹⁹-Asn-Hyp-Tyr-Thr-Lys-Arg-Cys²⁶-Tyr-NH₂ (disulfide bonds: 1 → 16; 8 → 19; 15 → 26)
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 26/27/28

      Very toxic by inhalation, in contact with skin and if swallowed.
      S PhraseS: 45-36/37/39

      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Wear suitable protective clothing, gloves and eye/face protection.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Highly Toxic
      Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      End use certificateY
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      343781-100UGCN 04055977195125

      Documentation

      ω-Conotoxin GVIA, Conus geographus - CAS 106375-28-4 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      ω-Conotoxin GVIA, Conus geographus - CAS 106375-28-4 - Calbiochem 試験成績書(CoA)

      タイトルロット番号
      343781

      参考資料

      参考資料の概要
      Lalo, U.V., et al. 2001. Brain Res. Bull. 54, 507.
      Kim, J.I., et al. 1995. Biochem. Biophys. Res. Commun. 206, 449.
      Abbott, J.R., and Litzinger, M.J. 1994. Int. J. Dev. Neurosci. 12, 43.
      Olivera, B.M., et al. 1991. J. Biol. Chem. 266, 22067.
      Protti, D.A., et al. 1991. Brain Res. 557, 336.
      Werth, J.L., et al. 1991. Mol. Pharmacol. 40, 742.
      Koyano, K., et al. 1987. Eur. J. Pharmacol. 135, 337.
      Abe, T., et al. 1986. Neurosci. Lett. 71, 203.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision24-June-2008 RFH
      Synonymsω-CgTx GVIA
      DescriptionA neurotoxin that acts as an antagonist of voltage-activated N-type Ca2+ channels and of neurotransmitter release at neuronal synapses. Its antagonistic activity is attributed to a tyrosine residue at position 13. Does not bind to dihydropyridine- or verapamil-binding sites. Also reported to inhibit ATP-induced inward currents mediated by P2X2/X3 receptors (IC50 = 21.2 nM for P2X3 and 3.84 µM for P2X2/X3 heterooligomeric receptors).
      FormLyophilized
      CAS number106375-28-4
      Chemical formulaC₁₂₀H₁₈₂N₃₈O₄₃S₆
      Peptide SequenceH-Cys¹-Lys-Ser-Hyp-Gly-Ser-Ser-Cys⁸-Ser-Hyp-Thr-Ser-Tyr-Asn-Cys¹⁵-Cys¹⁶-Arg-Ser-Cys¹⁹-Asn-Hyp-Tyr-Thr-Lys-Arg-Cys²⁶-Tyr-NH₂ (disulfide bonds: 1 → 16; 8 → 19; 15 → 26)
      Purity≥98% by HPLC
      SolubilityH₂O (250 µg/ml) or aqueous buffers
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Highly Toxic
      ReferencesLalo, U.V., et al. 2001. Brain Res. Bull. 54, 507.
      Kim, J.I., et al. 1995. Biochem. Biophys. Res. Commun. 206, 449.
      Abbott, J.R., and Litzinger, M.J. 1994. Int. J. Dev. Neurosci. 12, 43.
      Olivera, B.M., et al. 1991. J. Biol. Chem. 266, 22067.
      Protti, D.A., et al. 1991. Brain Res. 557, 336.
      Werth, J.L., et al. 1991. Mol. Pharmacol. 40, 742.
      Koyano, K., et al. 1987. Eur. J. Pharmacol. 135, 337.
      Abe, T., et al. 1986. Neurosci. Lett. 71, 203.